News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)

Al's Comment:

 Medicare is going to reconsider it's decision to not cover Optune.  The meeting is going to be streamed online but you have to register (free) soon. You can not comment at this meeting but they will have a follow up meeting where you can tell Medicare how you feel on this topic. It is important to watch this to show the support of the brain tumor community.


Posted on: 02/14/2019

Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)

https://med.noridianmedicare.com/web/jadme/policies/dmd-articles/2019/cac-meeting-information-tumor-treatment-field-therapy-l34823

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740